AU2002325827A1 - Compositions and methods for detecting or regulating cholesteryl ester transfer protein - Google Patents

Compositions and methods for detecting or regulating cholesteryl ester transfer protein

Info

Publication number
AU2002325827A1
AU2002325827A1 AU2002325827A AU2002325827A AU2002325827A1 AU 2002325827 A1 AU2002325827 A1 AU 2002325827A1 AU 2002325827 A AU2002325827 A AU 2002325827A AU 2002325827 A AU2002325827 A AU 2002325827A AU 2002325827 A1 AU2002325827 A1 AU 2002325827A1
Authority
AU
Australia
Prior art keywords
regulating
compositions
detecting
methods
transfer protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002325827A
Inventor
Zouher Majd
Jamila Najib-Fruchart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genfit SA
Original Assignee
Genfit SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit SA filed Critical Genfit SA
Publication of AU2002325827A1 publication Critical patent/AU2002325827A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002325827A 2001-06-07 2002-06-06 Compositions and methods for detecting or regulating cholesteryl ester transfer protein Abandoned AU2002325827A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01401468 2001-06-07
EP01401468.2 2001-06-07
PCT/EP2002/006228 WO2002098915A2 (en) 2001-06-07 2002-06-06 Compositions and methods for detecting or regulating cholesteryl ester transfer protein

Publications (1)

Publication Number Publication Date
AU2002325827A1 true AU2002325827A1 (en) 2002-12-16

Family

ID=8182759

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002325827A Abandoned AU2002325827A1 (en) 2001-06-07 2002-06-06 Compositions and methods for detecting or regulating cholesteryl ester transfer protein

Country Status (2)

Country Link
AU (1) AU2002325827A1 (en)
WO (1) WO2002098915A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2012122A1 (en) * 2007-07-06 2009-01-07 Medigene AG Mutated parvovirus structural proteins as vaccines
EP2532359A1 (en) 2011-06-10 2012-12-12 Affiris AG CETP fragments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06169793A (en) * 1992-12-02 1994-06-21 Eiken Chem Co Ltd Monoclonal antibody
US6410022B1 (en) * 1995-05-01 2002-06-25 Avant Immunotherapeutics, Inc. Modulation of cholesteryl ester transfer protein (CETP) activity
JPH0977798A (en) * 1995-09-08 1997-03-25 Wako Pure Chem Ind Ltd Antibody resistance to cholesteryl ester transfer protein
CA2302778A1 (en) * 1997-09-19 1999-04-01 Monsanto Company Dna vaccination against cholesterol ester transfer protein in the treatment of atherosclerosis

Also Published As

Publication number Publication date
WO2002098915A3 (en) 2003-11-20
WO2002098915A2 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
ZA200308561B (en) Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors.
AU2584399A (en) Point of sale device
AU2001239947A1 (en) Methods and compositions for regulating adipocytes
AU2001271720A1 (en) Methods and compositions for determining gene function
AU7859900A (en) Compositions and methods for wt1 specific immunotherapy
AU2002361623A1 (en) Methods and compositions for chromatography
AU2002338428A1 (en) Methods and systems for identifying proteins
AU2002355551A1 (en) Antisense modulation of cholesteryl ester transfer protein expression
AU5781800A (en) Methods and compositions for assaying analytes
AU2001249444A1 (en) Methods and compositions for the simultaneous detection of multiple analytes
AU3020899A (en) Compositions and methods for protein secretion
AU2002361548A1 (en) Compositions and methods for bacteria detection
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AU2002311759A1 (en) Methods and compositions for analyzing nucleic acids
AU6094200A (en) Nor gene compositions and methods for use thereof
AU2002218919A1 (en) Compositions and methods for regulating receptor clustering
AU2002325827A1 (en) Compositions and methods for detecting or regulating cholesteryl ester transfer protein
AU2003219719A1 (en) Methods and compositions for detecting differences between nucleic acids
AU2002332507A1 (en) Levothyroxine compositions and methods
AU4007899A (en) Compositions and methods for the pulmonary delivery of nucleic acids
AU2002248646A1 (en) Compositions and methods for modulating an immune response
AU2401001A (en) Means of stabilizing compositions and reagents
AU2002240921A1 (en) Medane genes and proteins
AU5931300A (en) Ringene compositions and methods for use thereof
AU2002362088A1 (en) Method and composition for inducing weight loss

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase